TRAX
First Tracks Biotherapeutics Inc
NASDAQ · Healthcare · Biotechnology · US
$40.46
−4.82%Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.95
- EPS estimate
- -$0.74
- Revenue actual
- —
- Revenue estimate
- $75.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -28.4%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 12, 2026